Reinaldo M Diaz's Net Worth
$2.63 Million
Who is Reinaldo M Diaz?
Reinaldo M Diaz has an estimated net worth of $2.63 Million. This is based on reported shares across multiple companies, which include VALENTIS INC, Inozyme Pharma, Inc., and Lexeo Therapeutics, Inc..
SEC CIK
Reinaldo M Diaz's CIK is 0001250086
Past Insider Trading and Trends
2003 was Reinaldo M Diaz's most active year for acquiring shares with 2 total transactions. Reinaldo M Diaz's most active month to acquire stocks was the month of November. 2004 was Reinaldo M Diaz's most active year for disposing of shares, totalling 83 transactions. Reinaldo M Diaz's most active month to dispose stocks was the month of October. 2003 saw Reinaldo M Diaz paying a total of $249,999.55 for 170,731 shares, this is the most they've acquired in one year. In 2004 Reinaldo M Diaz cashed out on 928,949 shares for a total of $2,880,267.46, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
VALENTIS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 2
| |||
Form 4
| -97.22% | -35.00 |
$2.50 | -$86.84 | 1 |
Apr 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 8
| |||
Form 4/A
| -7.13% | -67.26 |
$2.14 | -$144.19 | 876 |
Dec 10 - Dec 13
| |||
Form 4
| -95.85% | -774.48 |
$2.15 | -$1,667.52 | 35 |
Dec 15 - Dec 16
| |||
Form 4
| -10.90% | -68.00 |
$2.11 | -$143.48 | 556 |
Dec 14
| |||
Form 4
| -3.75% | -24.26 |
$2.13 | -$51.67 | 623 |
Dec 10 - Dec 13
| |||
Form 4
| -22.10% | -183.00 |
$2.39 | -$436.56 | 647 |
Dec 8 - Dec 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 3
| |||
Form 4
| -5.57% | -48.00 |
$1.99 | -$95.52 | 813 |
Dec 1
| |||
Form 4
| -5.09% | -47.00 |
$1.99 | -$93.68 | 876 |
Nov 19
| |||
Form 4
| -4.05% | -39.00 |
$2.02 | -$78.91 | 924 |
Nov 18
| |||
Form 4/A
| -9.18% | -97.50 |
$2.24 | -$218.61 | 964.01 |
Nov 3 - Nov 5
| |||
Form 4/A
| -18.76% | -828.50 |
$2.26 | -$1,804.47 | 3.59K |
Oct 26 - Nov 3
| |||
Form 4
| -18.94% | -926.00 |
$2.13 | -$2,023.29 | 3.96K |
Oct 26 - Nov 5
| |||
Form 4
| -3.29% | -35.00 |
$7.46 | -$261.17 | 1.03K |
Mar 3 - Mar 4
| |||
Form 4/A
| -25.92% | -372.00 |
$7.09 | -$2,636.91 | 1.06K |
Feb 27 - Mar 2
| |||
Form 4
| -19.95% | -439.00 |
$7.09 | -$3,111.48 | 1.76K |
Feb 27 - Mar 2
| |||
Form 4
| -59.63% | -925.00K |
$3.10 | -$2,867,500.00 | 626.33K |
Feb 18
| |||
Form 4/A
| +13.56% | 121.95K |
$2.05 | $249,999.55 | 1.02M |
Dec 31
| |||
| No matching records found | |||||||||
Inozyme Pharma, Inc. (INZY) Snapshot price: $5.365
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Lexeo Therapeutics, Inc. (LXEO) Snapshot price: $16.92
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||